Inventiva names Chris Benecchi chief operating officer - IVA News | RalliesInventiva names Chris Benecchi chief operating officer
I
IVA• Appointment and role
- Inventiva appointed Chris Benecchi as chief operating officer as it prepares for NATiV3 Phase 3 topline results for lanifibranor in Q4 2026.
- Benecchi will lead operational readiness ahead of a potential U.S. launch of lanifibranor in 2028, subject to regulatory approval.
Benecchi's background
- He was previously CEO of Motric Bio, an Aditum Bio company.
- Earlier roles included COO, chief business officer, and chief commercial officer at Sage Therapeutics, supporting the U.S. launch of ZURZUVAE.
ABG
•
